BioCentury | Jun 30, 2020
Product Development

Second death in Audentes gene therapy trial may highlight need for more careful dosing

...on Monday: Ultragenyx Pharmaceuticals Inc. (NASDAQ:RARE), GenSight Biologics S.A. (Euronext:SIGHT), Voyager Therapeutics Inc. (NASDAQ:VYGR) and Applied Genetic Technologies Corp....
BioCentury | Oct 1, 2019
Company News

Oct. 1 Company Quick Takes: NVS, Microsoft to use AI for drug R&D; plus AstraZeneca, Tmunity-CHOP and AGTC-Otonomy deals

...work and commercialization. Deal terms are undisclosed. AGTC, Otonomy to develop genetic deafness gene therapy Applied Genetic Technologies Corp....
...GPC2 - Glypican 2 Sandi Wong, Staff Writer Novartis AG Microsoft Corp. AstraZeneca plc Tmunity Therapeutics Inc. The Children's Hospital of Philadelphia Applied Genetic Technologies Corp. Otonomy...
BioCentury | Mar 4, 2019
Company News

Biogen to acquire ophthalmology gene therapy play Nightstar

...gene therapies for ophthalmology despite recent setbacks. In December, Biogen terminated a 2015 deal with Applied Genetic Technologies Corp....
BioCentury | Dec 14, 2018
Company News

Biogen returns gene therapies to AGTC on lack of clinical activity

...of runway. Applied Genetic Technologies Corp. (NASDAQ:AGTC), Alachua, Fla. Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Business: Gene therapy Allison Johnson XLRS (rAAV2tYF-CB-hRS1) Applied Genetic Technologies Corp. Biogen...
BioCentury | Dec 13, 2018
Company News

Biogen returns gene therapies to AGTC on lack of clinical activity

...cash, which the company said Wednesday will provide at least two years of runway. Allison Johnson XLRS (rAAV2tYF-CB-hRS1) Applied Genetic Technologies Corp. Biogen...
BioCentury | May 5, 2018
Product Development

Rebuilding Biogen’s brain

...to its gene therapy bench, currently focused in monogenic retinal disorders, via a partnership with Applied Genetic Technologies Corp....
BioCentury | Jan 19, 2018
Tools & Techniques

Synthetic expressions

...London . Source: Company presentation, company websites; BCIQ: BioCentury Online Intelligence Year Partner Purpose 2015 Applied Genetic Technologies Corp....
BioCentury | Sep 22, 2017
Company News

Management tracks: Unity, Shield, Tusk

...NYSE:LLY). Ophthalmic company Ocular Therapeutix Inc. (NASDAQ:OCUL) named Michael Goldstein CMO. He was CMO at Applied Genetic Technologies Corp....
BioCentury | Sep 19, 2017
Company News

Management tracks: OncoMed, Vividion, Spero

...EVP of patient access and corporate development and general counsel at Rosetta Genomics Ltd. (NASDAQ:ROSG). Applied Genetic Technologies Corp....
BioCentury | Sep 1, 2017
Company News

AGTC and the FFB partner to advance opthalmic research

...by AGTC. Applied Genetic Technologies Corp. (NASDAQ:AGTC), Alachua, Fla. Foundation Fighting Blindness Inc. , Columbia, Md. Business: Ophthalmic Shannon Lehnbeuter XLRP Applied Genetic Technologies Corp. Foundation...
Items per page:
1 - 10 of 71
BioCentury | Jun 30, 2020
Product Development

Second death in Audentes gene therapy trial may highlight need for more careful dosing

...on Monday: Ultragenyx Pharmaceuticals Inc. (NASDAQ:RARE), GenSight Biologics S.A. (Euronext:SIGHT), Voyager Therapeutics Inc. (NASDAQ:VYGR) and Applied Genetic Technologies Corp....
BioCentury | Oct 1, 2019
Company News

Oct. 1 Company Quick Takes: NVS, Microsoft to use AI for drug R&D; plus AstraZeneca, Tmunity-CHOP and AGTC-Otonomy deals

...work and commercialization. Deal terms are undisclosed. AGTC, Otonomy to develop genetic deafness gene therapy Applied Genetic Technologies Corp....
...GPC2 - Glypican 2 Sandi Wong, Staff Writer Novartis AG Microsoft Corp. AstraZeneca plc Tmunity Therapeutics Inc. The Children's Hospital of Philadelphia Applied Genetic Technologies Corp. Otonomy...
BioCentury | Mar 4, 2019
Company News

Biogen to acquire ophthalmology gene therapy play Nightstar

...gene therapies for ophthalmology despite recent setbacks. In December, Biogen terminated a 2015 deal with Applied Genetic Technologies Corp....
BioCentury | Dec 14, 2018
Company News

Biogen returns gene therapies to AGTC on lack of clinical activity

...of runway. Applied Genetic Technologies Corp. (NASDAQ:AGTC), Alachua, Fla. Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Business: Gene therapy Allison Johnson XLRS (rAAV2tYF-CB-hRS1) Applied Genetic Technologies Corp. Biogen...
BioCentury | Dec 13, 2018
Company News

Biogen returns gene therapies to AGTC on lack of clinical activity

...cash, which the company said Wednesday will provide at least two years of runway. Allison Johnson XLRS (rAAV2tYF-CB-hRS1) Applied Genetic Technologies Corp. Biogen...
BioCentury | May 5, 2018
Product Development

Rebuilding Biogen’s brain

...to its gene therapy bench, currently focused in monogenic retinal disorders, via a partnership with Applied Genetic Technologies Corp....
BioCentury | Jan 19, 2018
Tools & Techniques

Synthetic expressions

...London . Source: Company presentation, company websites; BCIQ: BioCentury Online Intelligence Year Partner Purpose 2015 Applied Genetic Technologies Corp....
BioCentury | Sep 22, 2017
Company News

Management tracks: Unity, Shield, Tusk

...NYSE:LLY). Ophthalmic company Ocular Therapeutix Inc. (NASDAQ:OCUL) named Michael Goldstein CMO. He was CMO at Applied Genetic Technologies Corp....
BioCentury | Sep 19, 2017
Company News

Management tracks: OncoMed, Vividion, Spero

...EVP of patient access and corporate development and general counsel at Rosetta Genomics Ltd. (NASDAQ:ROSG). Applied Genetic Technologies Corp....
BioCentury | Sep 1, 2017
Company News

AGTC and the FFB partner to advance opthalmic research

...by AGTC. Applied Genetic Technologies Corp. (NASDAQ:AGTC), Alachua, Fla. Foundation Fighting Blindness Inc. , Columbia, Md. Business: Ophthalmic Shannon Lehnbeuter XLRP Applied Genetic Technologies Corp. Foundation...
Items per page:
1 - 10 of 71